|
MAGED4B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62825308791525E-12 |
| Normal-vs-Stage2 |
1.73349999910144E-08 |
| Normal-vs-Stage3 |
1.77891035235689E-12 |
| Normal-vs-Stage4 |
1.65001345919791E-12 |
| Stage1-vs-Stage2 |
8.800000E-01 |
| Stage1-vs-Stage3 |
1.975630E-01 |
| Stage1-vs-Stage4 |
1.393590E-02 |
| Stage2-vs-Stage3 |
4.511600E-01 |
| Stage2-vs-Stage4 |
7.847900E-02 |
| Stage3-vs-Stage4 |
2.796400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62481139653892E-12 |
| Normal-vs-AfricanAmerican |
3.596100E-03 |
| Normal-vs-Asian |
9.60389545667795E-11 |
| Caucasian-vs-AfricanAmerican |
5.761000E-01 |
| Caucasian-vs-Asian |
6.505400E-01 |
| AfricanAmerican-vs-Asian |
4.839000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.04739994455372E-09 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
9.536000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.7036372312873E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(61-80Yrs) |
8.73079386565223E-13 |
| Normal-vs-Age(81-100Yrs) |
7.036600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.565800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.360600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.242800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.823200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.420400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.561400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.404420E-03 |
| Classical-VS-Follicular |
3.224400E-01 |
| Classical-VS-Other |
4.100400E-01 |
| Classical-VS-Normal |
1.82076576038526E-14 |
| Tall-VS-Follicular |
3.900300E-02 |
| Tall-VS-Other |
1.635420E-01 |
| Tall-VS-Normal |
1.62803104331033E-12 |
| Follicular-VS-Other |
3.277600E-01 |
| Follicular-VS-Normal |
2.91078272596224E-12 |
| Other-VS-Normal |
6.363800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.46229728115577E-14 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.230220E-02 |
|
|
